+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Antibody-Drug Conjugates (ADC): Market Overview - Product Thumbnail Image

Antibody-Drug Conjugates (ADC): Market Overview

  • Report
  • March 2024
  • 86 Pages
  • Global
From
Glioblastoma Multiforme (Gbm) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Glioblastoma Multiforme (Gbm) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 1378 Pages
  • Global
From
Non-Small Cell Lung Cancer (Nsclc): Epidemiology Forecast to 2032 - Product Thumbnail Image

Non-Small Cell Lung Cancer (Nsclc): Epidemiology Forecast to 2032

  • Report
  • February 2024
  • 72 Pages
  • Global
From
Glioblastoma Multiforme (GBM) - Competitive Landscape - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Competitive Landscape

  • Report
  • December 2023
  • 75 Pages
  • Global
From
Anal Cancer (AC) - Competitive Landscape - Product Thumbnail Image

Anal Cancer (AC) - Competitive Landscape

  • Report
  • December 2023
  • 77 Pages
  • Global
From
Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • November 2023
  • 121 Pages
  • Global
From
Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 1129 Pages
  • Global
From
Multiple Myeloma Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Multiple Myeloma Epidemiology Analysis and Forecast to 2032

  • Report
  • November 2023
  • 47 Pages
  • Global
From
Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • September 2023
  • 65 Pages
  • Global
From
Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • September 2023
  • 79 Pages
  • Global
From
Diabetic Nephropathy (DN) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Diabetic Nephropathy (DN) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2023
  • 76 Pages
  • Global
From
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2023
  • 72 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2023
  • 111 Pages
  • Global
From
Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2023
  • 68 Pages
  • Global
From
Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • June 2023
  • 74 Pages
  • Global
From
Immuno-Oncology - Thematic Intelligence - Product Thumbnail Image

Immuno-Oncology - Thematic Intelligence

  • Report
  • May 2023
  • 169 Pages
  • Global
From
Canada Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

Canada Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • Canada
From
Australia Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

Australia Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • Australia
From
India Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

India Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • India
From
Italy Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030 - Product Thumbnail Image

Italy Procedures using Implantable Ports Count by Segments (Implantable Ports Placed for Chemotherapy Treatments and Implantable Ports Placed for Other Indications) and Forecast to 2030

  • Report
  • May 2023
  • 15 Pages
  • Italy
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more